WHAT OUR CLIENTS SAY
“I worked with the GK team in my previous company, Scopus and was happy to renew the work with them again at Camtek. They are a great team, always ready to help, the fact that they are based here in Israel and understand both the Israeli and the US market is a great advantage. They are a true strategic partners for us that can provide advice on a wide range of capital markets related issues. I would very much recommend GK as an IR firm that can provide all that a US listed Israeli company would need.”
“I have been working with GK for the past decade on all our international IR needs, from writing up scripts to setting up meetings and roadshows for us. I found the team to be very knowledgeable, creative and responsive to all our needs at any time of the day, from the morning in Israel to the evening in the US.”
“I very much enjoy working with the GK team, for over 10 years now. I found their advice over the years to be very constrictive. The fact, that they are located in Israel makes my life easier as I can speak to them on my schedule and meet with them face to face whenever is needed, and at short notice. At the same time, they know and understand the US capital markets very well and we find their advice invaluable.”
Kenny is the co-founder of GK and has over 15 years experience in crafting compelling investor communications strategies. He has led the investor relations strategy of many leading US listed Israeli companies. Prior to GK, he was an equity research analyst at Credit Suisse covering Israel. He was formally a research analyst and technology consultant, with experience at Goldman Sachs and ABN-Amro Bank. Kenny has a masters in Finance and Management from Cambridge University, and a Research Masters in Machine Vision from the University of London.
Ehud HelftManaging Partner
Ehud has over 15 years experience in executing customized investor relations programs for many Tel-Aviv and US listed companies. In particular, he has experience with strategising investor relations programs for companies embarking on IPOs. He was formally an equity research analyst and most recently head of Israeli Equity Research at Credit Suisse. Ehud has an MBA from IESE, Barcelona.
Gavriel FrohweinSenior Market Intelligence Executive
Gavriel is responsible for contacts with the buy-side and sell side, with a broad network and close relations with investors and analysts. He has close to a decade of Wall Street experience. He was formerly the marketing director of Leadsco, Canada, aiding Financial Advisors in expanding their client base. Gavriel has a Bachelor of Business Commerce from Ryerson University, Toronto, Canada.
Danny SaksDirector of Biotech
Danny has extensive background with leading large US IR agencies. He was previously Managing Partner, specializing in life science companies, at The Financial Relations Board, the largest IR agency in the United States. He co-founded the Biotechnology/Pharmaceutical Industry Group of the National Investor Relations Institute. He also has key experience came from executive in-house IR positions in Israel at Taro Pharmaceuticals and at Abraxis BioScience in the US, as well as at two US medical technology startups.